Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Hims & Hers Health, Inc.
Report date June 06, 2024 · Filed June 10, 2024
Section 16 reporting ended · disclosed 2024-06-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 90,985 |
Reported balance
After 2024-06-06 transaction · row 1
1 source rowRow 1 · 2024-06-06 · Exercise / conversion · Acquired 19,707 · Balance 90,985 F1: The RSUs vested on June 6, 2024, the date of the company's 2024 annual stockholders meeting. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-06-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-06-06 · Exercise / conversion · Disposed 19,707 · Balance 0 F2: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2024 annual meeting of stockholders or (b) June 15, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The RSUs vested on June 6, 2024, the date of the company's 2024 annual stockholders meeting.
F2: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2024 annual meeting of stockholders or (b) June 15, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 06, 2024 Filed Jun 10, 2024 16:37 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 19,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000177 · wk-form4_1718051821.xml · derivative · entry 2 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 19,707 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2024 annual meeting of stockholders or (b) June 15, 2024. F2 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2024 annual meeting of stockholders or (b) June 15, 2024. F2 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2024 annual meeting of stockholders or (b) June 15, 2024. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 16:37 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 19,707 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-24-000177 · wk-form4_1718051821.xml · nonDerivative · entry 1 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The RSUs vested on June 6, 2024, the date of the company's 2024 annual stockholders meeting. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 18:02 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 9,122 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000077 · wk-form4_1710885756.xml · derivative · entry 2 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 9,122 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a three-year period, with (i) one-third of the RSUs vesting on March 15, 2022, (ii) one-third of the RSUs vesting on March 15, 2023 and (iii) one-third of the RSUs vesting on March 15, 2024. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a three-year period, with (i) one-third of the RSUs vesting on March 15, 2022, (ii) one-third of the RSUs vesting on March 15, 2023 and (iii) one-third of the RSUs vesting on March 15, 2024. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 18:02 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 9,122 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-24-000077 · wk-form4_1710885756.xml · nonDerivative · entry 1 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| August 09, 2023 Filed Aug 16, 2023 17:47 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 19,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000224 · wk-form4_1692222440.xml · derivative · entry 1 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,707 Underlying: Class A Common Stock · 19,707 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2024 annual meeting of stockholders or (b) June 15, 2024. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2024 annual meeting of stockholders or (b) June 15, 2024. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2024 annual meeting of stockholders or (b) June 15, 2024. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 16:49 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 25,659 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000142 · wk-form4_1685738951.xml · derivative · entry 2 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 25,659 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The RSUs vested on June 1, 2023, the date of the company's 2023 annual stockholder meeting. F1 · derivative.exercise_date: The RSUs vested on June 1, 2023, the date of the company's 2023 annual stockholder meeting. F1 · derivative.expiration_date: The RSUs vested on June 1, 2023, the date of the company's 2023 annual stockholder meeting. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 16:49 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 25,659 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-23-000142 · wk-form4_1685738951.xml · nonDerivative · entry 1 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The RSUs vested on June 1, 2023, the date of the company's 2023 annual stockholder meeting. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 16:12 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 9,122 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000083 · wf-form4_167908391597500.xml · derivative · entry 2 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,122 Underlying: Class A Common Stock · 9,122 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a three-year period, with (i) one-third of the RSUs vesting on March 15, 2022, (ii) one-third of the RSUs vesting on March 15, 2023 and (iii) one-third of the RSUs vesting on March 15, 2024. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a three-year period, with (i) one-third of the RSUs vesting on March 15, 2022, (ii) one-third of the RSUs vesting on March 15, 2023 and (iii) one-third of the RSUs vesting on March 15, 2024. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 16:12 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 9,122 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-23-000083 · wf-form4_167908391597500.xml · nonDerivative · entry 1 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| August 10, 2022 Filed Aug 11, 2022 16:37 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 25,659 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-22-000181 · wf-form4_166025025343926.xml · derivative · entry 1 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,659 Underlying: Class A Common Stock · 25,659 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs shall vest on June 15, 2023, subject to a service-based vesting requirement, which shall be satisfied on the date that is the earlier of (a) June 15, 2023 or (b) the date of the company's next-occurring annual stockholder meeting. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs shall vest on June 15, 2023, subject to a service-based vesting requirement, which shall be satisfied on the date that is the earlier of (a) June 15, 2023 or (b) the date of the company's next-occurring annual stockholder meeting. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs shall vest on June 15, 2023, subject to a service-based vesting requirement, which shall be satisfied on the date that is the earlier of (a) June 15, 2023 or (b) the date of the company's next-occurring annual stockholder meeting. Read SEC document |
| May 12, 2022 Filed May 16, 2022 20:36 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 1,842 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-22-000121 · wf-form4_165274774554720.xml · nonDerivative · entry 1 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,375 F1 · kind: Represents a pro-rata in-kind distribution of shares of Class A common stock, and not a purchase or sale, without consideration, which is therefore an exempt, non-matchable acquisition pursuant to Section 16(b). F1 · price: Represents a pro-rata in-kind distribution of shares of Class A common stock, and not a purchase or sale, without consideration, which is therefore an exempt, non-matchable acquisition pursuant to Section 16(b). Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 19:12 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 9,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-22-000091 · wf-form4_164755872189585.xml · derivative · entry 2 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,244 Underlying: Class A Common Stock · 9,121 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a three-year period, with (i) one-third of the RSUs vesting on March 15, 2022, (ii) one-third of the RSUs vesting on March 15, 2023 and (iii) one-third of the RSUs vesting on March 15, 2024, subject to the Reporting Person's continuous service with the issuer. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a three-year period, with (i) one-third of the RSUs vesting on March 15, 2022, (ii) one-third of the RSUs vesting on March 15, 2023 and (iii) one-third of the RSUs vesting on March 15, 2024, subject to the Reporting Person's continuous service with the issuer. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a three-year period, with (i) one-third of the RSUs vesting on March 15, 2022, (ii) one-third of the RSUs vesting on March 15, 2023 and (iii) one-third of the RSUs vesting on March 15, 2024, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 19:12 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 9,121 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-22-000091 · wf-form4_164755872189585.xml · nonDerivative · entry 1 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a three-year period, with (i) one-third of the RSUs vesting on March 15, 2022, (ii) one-third of the RSUs vesting on March 15, 2023 and (iii) one-third of the RSUs vesting on March 15, 2024, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 18:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 1,842 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-046609 · doc4.xml · nonDerivative · entry 1 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,412 F1 · kind: Represents a pro-rata in-kind distribution of shares of Class A common stock, and not a purchase or sale, without consideration, which is therefore an exempt, non-matchable acquisition pursuant to Section 16(b). The total shares reported includes 14,570 shares received from prior in-kind distributions by Maverick Ventures Advisors Fund L.P. and Maverick Ventures Investment Fund, L.P. F1 · price: Represents a pro-rata in-kind distribution of shares of Class A common stock, and not a purchase or sale, without consideration, which is therefore an exempt, non-matchable acquisition pursuant to Section 16(b). The total shares reported includes 14,570 shares received from prior in-kind distributions by Maverick Ventures Advisors Fund L.P. and Maverick Ventures Investment Fund, L.P. F1 · balance_after: Represents a pro-rata in-kind distribution of shares of Class A common stock, and not a purchase or sale, without consideration, which is therefore an exempt, non-matchable acquisition pursuant to Section 16(b). The total shares reported includes 14,570 shares received from prior in-kind distributions by Maverick Ventures Advisors Fund L.P. and Maverick Ventures Investment Fund, L.P. Read SEC document |
| August 13, 2021 Filed Aug 18, 2021 21:39 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 1,100,241 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-033584 · doc4.xml · nonDerivative · entry 2 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Maverick Ventures Investment Fund, L.P. Disclosed balance after: 0 F1 · kind: Represents a pro-rata in-kind distribution of shares of Class A common stock, and not a purchase or sale, without consideration to its partners. F1 · price: Represents a pro-rata in-kind distribution of shares of Class A common stock, and not a purchase or sale, without consideration to its partners. F2 · ownership.nature: The Reporting Person is a Member of Maverick Capital Ventures, LLC ("Maverick Ventures"), the general partner of Maverick Advisors Fund, L.P. and Maverick Ventures Investment Fund, L.P.. Read SEC document |
| August 13, 2021 Filed Aug 18, 2021 21:39 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 611,401 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-033584 · doc4.xml · nonDerivative · entry 1 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Maverick Advisors Fund, L.P. Disclosed balance after: 0 F1 · kind: Represents a pro-rata in-kind distribution of shares of Class A common stock, and not a purchase or sale, without consideration to its partners. F1 · price: Represents a pro-rata in-kind distribution of shares of Class A common stock, and not a purchase or sale, without consideration to its partners. F2 · ownership.nature: The Reporting Person is a Member of Maverick Capital Ventures, LLC ("Maverick Ventures"), the general partner of Maverick Advisors Fund, L.P. and Maverick Ventures Investment Fund, L.P.. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 21:00 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionWarrant (right to buy) · Derivative | 6,140 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000899243-21-032274 · doc4.xml · derivative · entry 6 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Maverick Ventures Investment Fund, L.P. Disclosed balance after: 0 Underlying: Class A Common Stock · 6,140 shares Expires 2026-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · ownership.nature: The Reporting Person is a Member of Maverick Capital Ventures, LLC ("Maverick Ventures"), the general partner of MAF LP and MVIF LP. The Reporting Person disclaims beneficial ownership of the securities held by MAF LP and MVIF LP and this report shall not be deemed an admission that he is the beneficial owner of such securities, except to the extent of his indirect pecuniary interest therein, if any, by virtue of his interest in Maverick Ventures. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 21:00 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionWarrant (right to buy) · Derivative | 3,412 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000899243-21-032274 · doc4.xml · derivative · entry 5 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Maverick Advisors Fund, L.P. Disclosed balance after: 0 Underlying: Class A Common Stock · 3,412 shares Expires 2026-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · ownership.nature: The Reporting Person is a Member of Maverick Capital Ventures, LLC ("Maverick Ventures"), the general partner of MAF LP and MVIF LP. The Reporting Person disclaims beneficial ownership of the securities held by MAF LP and MVIF LP and this report shall not be deemed an admission that he is the beneficial owner of such securities, except to the extent of his indirect pecuniary interest therein, if any, by virtue of his interest in Maverick Ventures. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 21:00 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 4,501 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-032274 · doc4.xml · nonDerivative · entry 4 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Maverick Ventures Investment Fund, L.P. Disclosed balance after: 1,100,241 F2 · kind: Represents shares of Class A Common Stock withheld in connection with the cashless exercises. F1 · price: Maverick Advisors Fund, L.P. ("MAF LP") and Maverick Ventures Investment Fund, L.P. ("MVIF LP") exercised warrants to purchase shares of the Issuer's Class A Common Stock on July 28, 2021. The warrants were exercised on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, MAF LP and MVIF LP received 0.267 shares per warrant exercised and the Issuer withheld 0.733 shares per warrant exercised. The exercise of the warrants, the withholding of shares of Class A Common Stock in the cashless exercises and the resulting issuance of the net shares of Class A Common Stock were exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended. F3 · ownership.nature: The Reporting Person is a Member of Maverick Capital Ventures, LLC ("Maverick Ventures"), the general partner of MAF LP and MVIF LP. The Reporting Person disclaims beneficial ownership of the securities held by MAF LP and MVIF LP and this report shall not be deemed an admission that he is the beneficial owner of such securities, except to the extent of his indirect pecuniary interest therein, if any, by virtue of his interest in Maverick Ventures. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 21:00 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 2,501 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-032274 · doc4.xml · nonDerivative · entry 3 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Maverick Advisors Fund, L.P. Disclosed balance after: 611,401 F2 · kind: Represents shares of Class A Common Stock withheld in connection with the cashless exercises. F1 · price: Maverick Advisors Fund, L.P. ("MAF LP") and Maverick Ventures Investment Fund, L.P. ("MVIF LP") exercised warrants to purchase shares of the Issuer's Class A Common Stock on July 28, 2021. The warrants were exercised on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, MAF LP and MVIF LP received 0.267 shares per warrant exercised and the Issuer withheld 0.733 shares per warrant exercised. The exercise of the warrants, the withholding of shares of Class A Common Stock in the cashless exercises and the resulting issuance of the net shares of Class A Common Stock were exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended. F3 · ownership.nature: The Reporting Person is a Member of Maverick Capital Ventures, LLC ("Maverick Ventures"), the general partner of MAF LP and MVIF LP. The Reporting Person disclaims beneficial ownership of the securities held by MAF LP and MVIF LP and this report shall not be deemed an admission that he is the beneficial owner of such securities, except to the extent of his indirect pecuniary interest therein, if any, by virtue of his interest in Maverick Ventures. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 21:00 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 6,140 | $11.50 | $70,610.00 |
DisclosureSEC source: 0000899243-21-032274 · doc4.xml · nonDerivative · entry 2 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Maverick Ventures Investment Fund, L.P. Disclosed balance after: 1,104,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Maverick Advisors Fund, L.P. ("MAF LP") and Maverick Ventures Investment Fund, L.P. ("MVIF LP") exercised warrants to purchase shares of the Issuer's Class A Common Stock on July 28, 2021. The warrants were exercised on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, MAF LP and MVIF LP received 0.267 shares per warrant exercised and the Issuer withheld 0.733 shares per warrant exercised. The exercise of the warrants, the withholding of shares of Class A Common Stock in the cashless exercises and the resulting issuance of the net shares of Class A Common Stock were exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended. F3 · ownership.nature: The Reporting Person is a Member of Maverick Capital Ventures, LLC ("Maverick Ventures"), the general partner of MAF LP and MVIF LP. The Reporting Person disclaims beneficial ownership of the securities held by MAF LP and MVIF LP and this report shall not be deemed an admission that he is the beneficial owner of such securities, except to the extent of his indirect pecuniary interest therein, if any, by virtue of his interest in Maverick Ventures. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 21:00 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 3,412 | $11.50 | $39,238.00 |
DisclosureSEC source: 0000899243-21-032274 · doc4.xml · nonDerivative · entry 1 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Maverick Advisors Fund, L.P. Disclosed balance after: 613,902 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Maverick Advisors Fund, L.P. ("MAF LP") and Maverick Ventures Investment Fund, L.P. ("MVIF LP") exercised warrants to purchase shares of the Issuer's Class A Common Stock on July 28, 2021. The warrants were exercised on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, MAF LP and MVIF LP received 0.267 shares per warrant exercised and the Issuer withheld 0.733 shares per warrant exercised. The exercise of the warrants, the withholding of shares of Class A Common Stock in the cashless exercises and the resulting issuance of the net shares of Class A Common Stock were exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended. F3 · ownership.nature: The Reporting Person is a Member of Maverick Capital Ventures, LLC ("Maverick Ventures"), the general partner of MAF LP and MVIF LP. The Reporting Person disclaims beneficial ownership of the securities held by MAF LP and MVIF LP and this report shall not be deemed an admission that he is the beneficial owner of such securities, except to the extent of his indirect pecuniary interest therein, if any, by virtue of his interest in Maverick Ventures. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 17:26 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 27,365 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014241 · doc4.xml · derivative · entry 1 Bhattacharyya Ambar · CIK 0001849899 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,365 Underlying: Class A Common Stock · 27,365 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a three-year period, with (i) one-third of the RSUs vesting on March 15, 2022, (ii) one-third of the RSUs vesting on March 15, 2023 and (iii) one-third of the RSUs vesting on March 15, 2024, subject to the Reporting Person's continuous service with the issuer on each vesting date. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a three-year period, with (i) one-third of the RSUs vesting on March 15, 2022, (ii) one-third of the RSUs vesting on March 15, 2023 and (iii) one-third of the RSUs vesting on March 15, 2024, subject to the Reporting Person's continuous service with the issuer on each vesting date. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a three-year period, with (i) one-third of the RSUs vesting on March 15, 2022, (ii) one-third of the RSUs vesting on March 15, 2023 and (iii) one-third of the RSUs vesting on March 15, 2024, subject to the Reporting Person's continuous service with the issuer on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.